Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from PainChek Ltd ( (AU:PCK) ).
PainChek Ltd has applied to the ASX for quotation of 24,775 new fully paid ordinary shares following the exercise or conversion of existing options or other convertible securities, with an issue date of 23 December 2025. The relatively small share issuance modestly increases the company’s quoted capital base and reflects ongoing conversion of incentive or financing-related instruments, with limited immediate impact on its overall capital structure but indicating continued engagement from holders of convertible securities.
More about PainChek Ltd
PainChek Ltd is an Australian-listed healthcare technology company that trades on the ASX under the code PCK. The company focuses on developing and commercialising digital tools and related technologies aimed at assessing and managing patient pain, serving clinical and aged-care markets where objective pain measurement is critical.
Average Trading Volume: 461,752
Technical Sentiment Signal: Sell
Current Market Cap: A$58.47M
For detailed information about PCK stock, go to TipRanks’ Stock Analysis page.